@inproceedings{inproceedings, title  = {{Efficacy and safety of tralokinumab in adolescents with moderate-to- severe atopic dermatitis: results of the phase 3 ECZTRA 6 trial}},

 publisher = {{National Society for Cutaneous Medicine}},

 url = {{}},

 year = {{2022}},

 month = {{3}},

 author = {{Paller A and Blauvelt A and Soong W and Imafuku S and Hong C-H and Schuttelaar M and Amoudruz P and Kurbasic A and Soldbro L and Lophaven K and Cork M et al}},

 doi = {{10.25251/skin.6.supp.s29}},

 volume = {{6}},

 journal = {{SKIN The Journal of Cutaneous Medicine}},

 issue = {{2}},

 pages = {{s29-s29}},

 note = {{Accessed on 2024/12/22}}}